{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:42:26Z","timestamp":1761597746132},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1038\/gene.2016.36","type":"journal-article","created":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T09:01:54Z","timestamp":1475744514000},"page":"396-399","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of KIR3DL1\/KIR3DS1 polymorphism in Beh\u00e7et\u2019s disease"],"prefix":"10.1038","volume":"17","author":[{"given":"B","family":"Erer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Ustek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Tugal-Tutkun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Seyahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"\u00d6zyazgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Duymaz-Tozkir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D L","family":"Kastner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E F","family":"Remmers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Ombrello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,6]]},"reference":[{"key":"BFgene201636_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G . Behcet's disease. N Engl J Med 1999; 341: 1284\u20131291.","journal-title":"N Engl J Med"},{"key":"BFgene201636_CR2","first-page":"483","volume":"150","author":"T Lehner","year":"1999","unstructured":"Lehner T . Immunopathogenesis of Behcet's disease. Ann Med Interne (Paris) 1999; 150: 483\u2013487.","journal-title":"Ann Med Interne (Paris)"},{"key":"BFgene201636_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3109\/08830189709116847","volume":"14","author":"T Sakane","year":"1997","unstructured":"Sakane T . New perspective on Behcet's disease. Int Rev Immunol 1997; 14: 89\u201396.","journal-title":"Int Rev Immunol"},{"key":"BFgene201636_CR4","first-page":"S96","volume":"23","author":"P Fietta","year":"2005","unstructured":"Fietta P . Behcet's disease: familial clustering and immunogenetics. Clin Exp Rheumatol 2005; 23: S96\u2013105.","journal-title":"Clin Exp Rheumatol"},{"key":"BFgene201636_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/ard.59.8.622","volume":"59","author":"A Gul","year":"2000","unstructured":"Gul A, Inanc M, Ocal L, Aral O, Konice M . Familial aggregation of Behcet's disease in Turkey. Ann Rheum Dis 2000; 59: 622\u2013625.","journal-title":"Ann Rheum Dis"},{"key":"BFgene201636_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ng.2520","volume":"45","author":"Y Kirino","year":"2013","unstructured":"Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E et al. Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 2013; 45: 202\u2013207.","journal-title":"Nat Genet"},{"key":"BFgene201636_CR7","doi-asserted-by":"publisher","first-page":"8134","DOI":"10.1073\/pnas.1306352110","volume":"110","author":"Y Kirino","year":"2013","unstructured":"Kirino Y, Zhou Q, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E et al. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease. Proc Natl Acad Sci USA 2013; 110: 8134\u20138139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene201636_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ng.624","volume":"42","author":"N Mizuki","year":"2010","unstructured":"Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat Genet 2010; 42: 703\u2013706.","journal-title":"Nat Genet"},{"key":"BFgene201636_CR9","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet 2010; 42: 698\u2013702.","journal-title":"Nat Genet"},{"key":"BFgene201636_CR10","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/art.24642","volume":"61","author":"M deMenthon","year":"2009","unstructured":"deMenthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A . HLA-B51\/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009; 61: 1287\u20131296.","journal-title":"Arthritis Rheum"},{"key":"BFgene201636_CR11","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/S0140-6736(73)93343-6","volume":"2","author":"S Ohno","year":"1973","unstructured":"Ohno S, Aoki K, Sugiura S, Nakayama E, Itakura K., Letter et al. and Behcet's disease. Lancet 1973; 2: 1383\u20131384.","journal-title":"Lancet"},{"key":"BFgene201636_CR12","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/archopht.1982.01030040433013","volume":"100","author":"S Ohno","year":"1982","unstructured":"Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M . Close association of HLA-Bw51 with Behcet's disease. Arch Ophthalmol 1982; 100: 1455\u20131458.","journal-title":"Arch Ophthalmol"},{"key":"BFgene201636_CR13","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1073\/pnas.1406575111","volume":"111","author":"MJ Ombrello","year":"2014","unstructured":"Ombrello MJ, Kirino Y, de Bakker PI, Gul A, Kastner DL, Remmers EF . Behcet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity. Proc Natl Acad Sci USA 2014; 111: 8867\u20138872.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene201636_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1124\/mi.5.4.6","volume":"5","author":"AP Williams","year":"2005","unstructured":"Williams AP, Bateman AR, Khakoo SI . Hanging in the balance. KIR and their role in disease. Mol Interv 2005; 5: 226\u2013240.","journal-title":"Mol Interv"},{"key":"BFgene201636_CR15","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.4049\/jimmunol.1002653","volume":"186","author":"P Bowness","year":"2011","unstructured":"Bowness P, Ridley A, Shaw J, Chan AT, Wong-Baeza I, Fleming M et al. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol 2011; 186: 2672\u20132680.","journal-title":"J Immunol"},{"key":"BFgene201636_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1371\/journal.pgen.0010027","volume":"1","author":"J Kelley","year":"2005","unstructured":"Kelley J, Walter L, Trowsdale J . Comparative genomics of natural killer cell receptor gene clusters. PLoS Genet 2005; 1: 129\u2013139.","journal-title":"PLoS Genet"},{"key":"BFgene201636_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1471-2164-14-89","volume":"14","author":"CW Pyo","year":"2013","unstructured":"Pyo CW, Wang R, Vu Q, Cereb N, Yang SY, Duh FM et al. Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. BMC Genomics 2013; 14: 89.","journal-title":"BMC Genomics"},{"key":"BFgene201636_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1034\/j.1399-0039.2003.00072.x","volume":"62","author":"SG Marsh","year":"2003","unstructured":"Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens 2003; 62: 79\u201386.","journal-title":"Tissue Antigens"},{"key":"BFgene201636_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4049\/jimmunol.178.1.33","volume":"178","author":"H Thananchai","year":"2007","unstructured":"Thananchai H, Gillespie G, Martin MP, Bashirova A, Yawata N, Yawata M et al. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 2007; 178: 33\u201337.","journal-title":"J Immunol"},{"key":"BFgene201636_CR20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1084\/jem.20152023","volume":"213","author":"PM Saunders","year":"2016","unstructured":"Saunders PM, Pymm P, Pietra G, Hughes VA, Hitchen C, O'Connor GM et al. Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition. J Exp Med 2016; 213: 791\u2013807.","journal-title":"J Exp Med"},{"key":"BFgene201636_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng934","volume":"31","author":"MP Martin","year":"2002","unstructured":"Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31: 429\u2013434.","journal-title":"Nat Genet"},{"key":"BFgene201636_CR22","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1371\/journal.ppat.0020079","volume":"2","author":"Y Qi","year":"2006","unstructured":"Qi Y, Martin MP, Gao X, Jacobson L, Goedert JJ, Buchbinder S et al. KIR\/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog 2006; 2: e79.","journal-title":"PLoS Pathog"},{"key":"BFgene201636_CR23","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.4049\/jimmunol.158.11.5237","volume":"158","author":"JE Gumperz","year":"1997","unstructured":"Gumperz JE, Barber LD, Valiante NM, Percival L, Phillips JH, Lanier LL et al. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol 1997; 158: 5237\u20135241.","journal-title":"J Immunol"},{"key":"BFgene201636_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.humimm.2008.04.012","volume":"69","author":"R Diaz-Pena","year":"2008","unstructured":"Diaz-Pena R, Blanco-Gelaz MA, Suarez-Alvarez B, Martinez-Borra J, Lopez-Vazquez A, Alonso-Arias R et al. Activating KIR genes are associated with ankylosing spondylitis in Asian populations. Hum Immunol 2008; 69: 437\u2013442.","journal-title":"Hum Immunol"},{"key":"BFgene201636_CR25","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1186\/ar1988","volume":"8","author":"C Lopez-Larrea","year":"2006","unstructured":"Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC, Bruges Armas J, Suarez-Alvarez B, Pruneda L et al. Contribution of KIR3DL1\/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations. Arthritis Res Ther 2006; 8: R101.","journal-title":"Arthritis Res Ther"},{"key":"BFgene201636_CR26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/ard.2008.095927","volume":"68","author":"D Harvey","year":"2009","unstructured":"Harvey D, Pointon JJ, Sleator C, Meenagh A, Farrar C, Sun JY et al. Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis. Ann Rheum Dis 2009; 68: 595\u2013598.","journal-title":"Ann Rheum Dis"},{"key":"BFgene201636_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1399-0039.2009.01392.x","volume":"75","author":"J McCappin","year":"2010","unstructured":"McCappin J, Harvey D, Wordsworth BP, Middleton D . No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis. Tissue Antigens 2010; 75: 68\u201373.","journal-title":"Tissue Antigens"},{"key":"BFgene201636_CR28","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.4049\/jimmunol.1202926","volume":"190","author":"I Wong-Baeza","year":"2013","unstructured":"Wong-Baeza I, Ridley A, Shaw J, Hatano H, Rysnik O, McHugh K et al. KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis. J Immunol 2013; 190: 3216\u20133224.","journal-title":"J Immunol"},{"key":"BFgene201636_CR29","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1399-0039.2007.00929.x","volume":"70","author":"D Middleton","year":"2007","unstructured":"Middleton D, Meenagh A, Sleator C, Gourraud PA, Ayna T, Tozkir H et al. No association of KIR genes with Behcet's disease. Tissue Antigens 2007; 70: 435\u2013438.","journal-title":"Tissue Antigens"},{"key":"BFgene201636_CR30","doi-asserted-by":"publisher","first-page":"R116","DOI":"10.1186\/ar4569","volume":"16","author":"AB Kuranov","year":"2014","unstructured":"Kuranov AB, Kotter I, Henes JC, Abisheva ST, Steiert I, Riewerts F et al. Behcet's disease in HLA-B*51 negative Germans and Turks shows association with HLA-Bw4-80I. Arthritis Res Ther 2014; 16: R116.","journal-title":"Arthritis Res Ther"},{"key":"BFgene201636_CR31","first-page":"1078","volume":"335","author":"Disease ISGfBs","year":"1990","unstructured":"Disease ISGfBs. Criteria for diagnosis of Behcet's disease. Lancet 1990; 335: 1078\u20131080.","journal-title":"Lancet"},{"key":"BFgene201636_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1399-0039.2007.00923.x","volume":"70","author":"C Vilches","year":"2007","unstructured":"Vilches C, Castano J, Gomez-Lozano N, Estefania E . Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens 2007; 70: 415\u2013422.","journal-title":"Tissue Antigens"},{"key":"BFgene201636_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/978-1-61779-842-9_24","volume":"882","author":"D Ordonez","year":"2012","unstructured":"Ordonez D, Moraru M, Gomez-Lozano N, Cisneros E, Vilches C . KIR typing by non-sequencing methods: polymerase-chain reaction with sequence-specific primers. Methods Mol Biol 2012; 882: 415\u2013430.","journal-title":"Methods Mol Biol"},{"key":"BFgene201636_CR34","doi-asserted-by":"publisher","first-page":"e64683","DOI":"10.1371\/journal.pone.0064683","volume":"8","author":"X Jia","year":"2013","unstructured":"Jia X, Han B, Onengut-Gumuscu S, Chen W-M, Concannon PJ, Rich SS et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One 2013; 8: e64683.","journal-title":"PLoS One"}],"container-title":["Genes & Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gene201636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201636","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T10:26:23Z","timestamp":1692527183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gene201636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,6]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["BFgene201636"],"URL":"https:\/\/doi.org\/10.1038\/gene.2016.36","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,6]]},"assertion":[{"value":"13 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}